FDA panel schedules review for U-Systems' somo•v ABUS system
 

U-Systems, the leader in automated breast ultrasound, today announced the somo•v Automated Breast Ultrasound (ABUS) system has been scheduled for review by the Radiological Devices Panel of the U.S. Food & Drug Administration (FDA) on April 11, 2012.

More...